The Full Wiki

More info on Inolimomab

Inolimomab: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Inolimomab ?
Monoclonal antibody
Type whole antibody
Source mouse
Target CD25
Identifiers
CAS number 152981-31-2
ATC code none
Chemical data
Formula  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status

Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.[1][2]

References

  1. ^ Piñana JL, Valcárcel D, Martino R, et al. (November 2006). "Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease". Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 12 (11): 1135–41. doi:10.1016/j.bbmt.2006.06.010. PMID 17085306. http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(06)00453-8. 
  2. ^ Dartois; Freyer, G; Michallet, M; Hénin, E; You, B; Darlavoix, I; Vermot-Desroches, C; Tranchand, B et al. (2007). "Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease". Clinical pharmacokinetics 46 (5): 417–32. doi:10.2165/00003088-200746050-00004. PMID 17465640.  edit
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message